We first applied a GM-CSF blocking antibody to MC38 tumor-bearing responder mice (CC75×B6) using standard protocols60 (Figure 4B) and assessed the Cxcl9/Spp1 ratio 48 h after administration. This evidence concerns the gene CXCL9 and neoplasm.